Skip to content

13F-HR filed by Artal Group S.A.

Artal Group S.A. filed this 13F-HR for the quarter ended 2017-09-30, filed 2017-11-08, with 111 holding rows worth $5,805,179,000.

Accession
0001053906-17-000006
Filed
2017-11-08
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2017

A holdings report, 113 entries on the cover page, a total value of $5,805,179,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $5,805,179,000 with VALUE read as thousands by filing date, 13F file number 028-15027. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BLUE BUFFALO PET PRODS INC09531U102COM87,460,875$2,479,516,000thousands by filing date
WEIGHT WATCHERS INTL INC948626106COM29,443,300$1,282,256,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK57,517,977$706,896,000thousands by filing date
Bank of America Corp060505104COM9,850,000$249,599,000thousands by filing datecall
Goldman Sachs Group,Inc.38141G104COM200,000$47,438,000thousands by filing datecall
INCYTE CORP COM45337C102Stock400,000$46,696,000thousands by filing date
Bristol-Myers Squibb Company110122108COM650,000$41,431,000thousands by filing datecall
ALLERGAN PLCG0177J108SHS200,000$40,990,000thousands by filing datecall
Wells Fargo & Company949746101COM650,000$35,848,000thousands by filing datecall
AGIOS PHARMACEUTICALS INC00847X104COM450,000$30,038,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM1,250,000$30,000,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock250,000$29,373,000thousands by filing date
International Business Machines Corporation459200101COM200,000$29,016,000thousands by filing datecall
ACCELERON PHARMA INC00434H108COM700,000$26,124,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM400,000$24,512,000thousands by filing date
AMERICAN AIRLINES GROUP INC COM02376R102Stock500,000$23,745,000thousands by filing datecall
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR225,000$23,279,000thousands by filing date
BLACKROCK INC CL A COM09247X101COM50,000$22,355,000thousands by filing datecall
Citigroup Inc.172967424COM300,000$21,822,000thousands by filing datecall
METLIFE INC COM59156R108Stock400,000$20,780,000thousands by filing datecall
Gilead Sciences,Inc.375558103COM250,000$20,255,000thousands by filing datecall
Intel Corp458140100COM500,000$19,040,000thousands by filing datecall
Amgen Inc.031162100COM100,000$18,645,000thousands by filing datecall
BIOMARIN PHARMACEUTICAL INC09061G101COM200,000$18,614,000thousands by filing date
BLUEBIRD BIO INC09609G100COM135,000$18,542,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock1,500,000$18,450,000thousands by filing date
INCYTE CORP COM45337C102Stock150,000$17,511,000thousands by filing datecall
AMICUS THERAPEUTICS INC03152W109COM1,000,000$15,080,000thousands by filing datecall
Morgan Stanley617446448COM300,000$14,451,000thousands by filing datecall
NEKTAR THERAPEUTICS640268108COM600,000$14,400,000thousands by filing datecall
RADIUS HEALTH INC750469207COM NEW350,000$13,493,000thousands by filing datecall
TERADYNE INC COM880770102Stock350,000$13,052,000thousands by filing datecall
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK816,879$12,882,000thousands by filing date
58 COM INC31680Q104SPON ADR REP A200,000$12,628,000thousands by filing datecall
ARRAY BIOPHARMA INC COM04269X105Stock1,000,000$12,300,000thousands by filing datecall
AVEXIS INC05366U100COM120,000$11,608,000thousands by filing date
IGNYTA INC451731103COM900,000$11,115,000thousands by filing date
MEDICINES CO584688105COM300,000$11,112,000thousands by filing date
AGENUS INC00847G705COM NEW2,500,000$11,025,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM700,000$10,556,000thousands by filing date
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock600,000$9,930,000thousands by filing date
TESARO INC881569107COM75,000$9,683,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW250,000$9,638,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM115,000$9,476,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM150,000$9,345,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM300,000$9,315,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM100,000$9,307,000thousands by filing datecall
SAREPTA THERAPEUTICS INC803607100COM200,000$9,072,000thousands by filing date
JUNO THERAPEUTICS INC48205A109COM200,000$8,972,000thousands by filing datecall
SERES THERAPEUTICS INC81750R102COM550,000$8,822,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM250,000$7,763,000thousands by filing datecall
MEDICINES CO584688105COM200,000$7,408,000thousands by filing datecall
PROQR THERAPEUTICS NVN71542109SHS EURO1,500,000$7,275,000thousands by filing date
BLUEBIRD BIO INC09609G100COM50,000$6,868,000thousands by filing datecall
JUNO THERAPEUTICS INC48205A109COM150,000$6,729,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS500,000$6,340,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS500,000$6,340,000thousands by filing datecall
ALDER BIOPHARMACEUTICALS INC014339105COM500,000$6,125,000thousands by filing date
AUDENTES THERAPEUTICS INC.05070R104Common Stock200,000$5,602,000thousands by filing date
AC IMMUNE SAH00263105SHS500,000$5,585,000thousands by filing date
SEATTLE GENETICS INC812578102COM100,000$5,441,000thousands by filing datecall
REGENXBIO INC75901B107COM160,000$5,272,000thousands by filing date
ANAPTYSBIO INC032724106COM150,000$5,243,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock400,000$4,740,000thousands by filing date
ELFBEAUTYINC26856L103STOK200,000$4,510,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM1,000,000$4,490,000thousands by filing date
Accelerate Diagnostics00430H102COM200,000$4,490,000thousands by filing date
VITAL THERAPIES INC92847R104COM875,000$4,419,000thousands by filing date
INTELLIA THERAPEUTICS INC45826J105COM175,000$4,349,000thousands by filing date
ADAPTIMMUNE THERAPEUTICS PLC00653A107SPONDS ADR500,000$4,095,000thousands by filing date
ACHAOGEN INC004449104COM250,000$3,988,000thousands by filing date
CHEMOCENTRYX INC16383L106COM500,000$3,710,000thousands by filing date
MACROGENICS INC556099109COM200,000$3,696,000thousands by filing date
Bowater Inc09066L105COMMON STOCKS1,282,050$3,641,000thousands by filing date
VERASTEM INC92337C104COM750,000$3,525,000thousands by filing date
ZAFGEN INC98885E103COM1,000,000$3,520,000thousands by filing date
AXOVANT SCIENCES LTDG0750W104COM500,000$3,440,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock650,000$3,406,000thousands by filing date
TESARO INC881569107COM25,000$3,228,000thousands by filing datecall
DYNAVAX TECHNOLOGIES CORP268158201COM NEW150,000$3,225,000thousands by filing date
JOUNCE THERAPEUTICS INC481116101COM200,000$3,116,000thousands by filing date
CELLECTIS ADS15117K103COM100,000$2,845,000thousands by filing date
GLYCOMIMETICS INC38000Q102COM202,500$2,833,000thousands by filing date
STEMLINE THERAPEUTICS INC85858C107COM250,000$2,775,000thousands by filing date
CALITHERA BIOSCIENCES INC COM NEW13089P101Stock175,000$2,756,000thousands by filing date
FIBROGEN INC31572Q808COM50,000$2,690,000thousands by filing date
ULTRAGENYX PHARMACEUTICAL IN90400D108COM50,000$2,663,000thousands by filing date
CHIMERIX INC COM16934W106Stock500,000$2,625,000thousands by filing date
BELLICUM PHARMACEUTICALS INC079481107COM200,000$2,310,000thousands by filing datecall
XENCOR INC98401F105COMMON STOCK100,000$2,292,000thousands by filing date
CHINOOK THERAPEUTICS INC.00739L101Common Stock200,000$2,130,000thousands by filing date
FIVE PRIME THERAPEUTICS INC.33830X104Common Stock50,000$2,046,000thousands by filing date
NEWLINK GENETICS CORP651511107COM200,000$2,036,000thousands by filing datecall
CELLDEX THERAPEUTICS INC NEW15117B103COM675,000$1,931,000thousands by filing date
MINERVA NEUROSCIENCES INC COM NEW603380106Stock251,300$1,910,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM50,000$1,869,000thousands by filing date
NOVELION THERAPEUTICS INC67001K202COM NEW256,400$1,802,000thousands by filing date
SYNDAX PHARMACEUTICALS INC87164F105COM152,920$1,789,000thousands by filing date
NEWLINK GENETICS CORP651511107COM150,000$1,527,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock100,000$1,495,000thousands by filing date
DIMENSION THERAPEUTICS INC25433V105COM234,493$1,407,000thousands by filing date
ATYR PHARMA INC002120103COM250,000$1,263,000thousands by filing date
NANTKWEST INC63016Q102COM225,000$1,233,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR54,337$1,229,000thousands by filing date
ONCOCYTE CORP68235C107COM150,000$1,133,000thousands by filing date
CORBUS PHARMACEUTICALS HLDGS21833P103COM150,000$1,073,000thousands by filing date
KRYSTAL BIOTECH INC COM501147102Stock100,000$997,000thousands by filing date
VERSARTIS INC92529L102COM400,000$980,000thousands by filing date
MIRAGEN THERAPEUTICS INC60463E103COM100,000$915,000thousands by filing date
NOVAVAX INC670002104COMMON STOCK500,000$570,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock150,000$443,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001053906-17-000006this filing2017-11-08acceptance time not in the bulk data set